We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Report: Drug Companies Spend More on Executive Pay and Stock Buybacks Than on Research
Report: Drug Companies Spend More on Executive Pay and Stock Buybacks Than on Research
Fourteen of the world’s largest drug companies spend millions of dollars more on stock buybacks and executive compensation than they do on research and development, a new congressional report has concluded.